A cross-sectional cost analysis for retrospective 6 months was conducted in 294 primary care patients with MUS. Health care utilisation and loss of productivity were measured by questionnaires. SSS was measured using the ¡°Patient Health Questionnaire 15¡± (PHQ-15). Direct and indirect costs and the association of costs with SSS were analysed via multiple linear regression analysis.
Patients with MUS had average 6-month direct costs of 1098 EUR and indirect costs of 7645 EUR. For direct costs, outpatient physician visits were the most expensive single cost category (36 % ), followed by pharmaceuticals (25 % ) and hospital stays (19 % ). Indirect costs were predominantly caused by productivity reduction at work (56 % ) followed by early retirement (29 % ) and acute sickness absence (14 % ). As compared to mild SSS, moderate SSS was not significantly associated with direct, but with indirect costs (+ 2948 EUR; p < .001); severe SSS was associated with increased direct cost (+ 658 EUR; p = .001) and increased indirect costs (+ 4630 EUR; p < .001). Age was positively associated with direct cost (+ 15 EUR for each additional year; p = .015) as well as indirect cost (+ 104 EUR for each additional year; p < .001).
MUS are associated with relevant direct and even much higher indirect costs that strongly depend on SSS.